GENEURO
GeNeuro is a biotechnology company that develops therapeutic drugs for diseases associated with the expression of pathogenic proteins of the human endogenous retroviral origin. The company is primarily focused on nervous system diseases such as multiple sclerosis and schizophrenia. Its products include GNbAC1, a therapeutic monoclonal antibody for the treatment of multiple sclerosis. It also develops diagnostic tests to dose the multiple sclerosis-associated retrovirus-ENV proteins in patients.GeNeuro was founded in 2006 and is based in Plan-Les-Ouates, Switzerland.
GENEURO
Industry:
Biotechnology Health Care Therapeutics
Founded:
2006-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.geneuro.com
Total Employee:
11+
Status:
Active
Contact:
+41227945085
Email Addresses:
[email protected]
Total Funding:
41.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Content Delivery Network Google Universal Analytics Apache Euro PHP
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Institut Merieux
Institut Merieux investment in Post-IPO Equity - GeNeuro
Invesco
Invesco investment in Post-IPO Equity - GeNeuro
Federal Office of Public Health (FOPH) Switzerland
Federal Office of Public Health (FOPH) Switzerland investment in Grant - GeNeuro
Eclosion SA
Eclosion SA investment in Venture Round - GeNeuro
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-21 | GeNeuro Appoints MS Clinical Development Expert Dr. David Leppert as Chief Medical Officer |
Official Site Inspections
http://www.geneuro.com Semrush global rank: 7.53 M Semrush visits lastest month: 462
- Host name: h2web367.infomaniak.ch
- IP address: 83.166.133.74
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
